4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013030
Chief Financial Officer sold 38,000 shares at $7.16 ($272,080)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PETERSON TYCHO Chief Financial Officer | 2023-06-02 | Sale | −38,000 | $7.16 | $272,080 | 454,891 | D: show line 1 in the form |
| Open-market sales · 38,000 sh · avg $7.16 · $272,080 | |||||||
Loading xslF345X04/form4.xml…